Physician

Miriah Michael Teeter, M.D.

According to 2025 Medicare claims, Miriah Teeter, M.D. (NPI: 1316141872) practices ophthalmology in the Denver-Aurora-Centennial, CO market, with the plurality of this provider's patient population coming from Arapahoe, CO. This provider's primary affiliated billing organization is COLORADO RETINA ASSOCIATES, PLLC (NPI: 1790876159; TIN: 203288374) and primary practice location at 80120-5715.

Teeter's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 743 traditional Medicare patients, billed 43,884 HCPCS/CPT codes, and received $3,539,033 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 205 prescription claims across 124 beneficiaries totaling $6,396 in drug costs, led by Neomycin-Polymyxin-Dexameth (Neomycin/Polymyxin B/Dexametha). Open Payments data shows 25 records totaling $1,106. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $672,170 to $3,539,033. In contrast, Part D prescription costs have moved from a higher plateau to a lower plateau, from $12,766 to $6,396. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.8M$3.5M2015 Medicare payment: $672,170 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $757,442 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $819,419 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $821,909 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $438,437 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $828,505 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,051,049 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,695,575 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,979,712 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $3,539,033 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20157444,783$672,170
20166775,098$757,442
20176155,059$819,419
20186455,275$821,909
20194852,987$438,437
20205214,263$828,505
20215865,234$1,051,049
20227607,783$1,695,575
202373518,546$1,979,712
202474343,884$3,539,033

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$13K$26K2015 Drug cost: $12,766 (USD; Tot_Drug_Cst)2016 Drug cost: $14,611 (USD; Tot_Drug_Cst)2017 Drug cost: $20,674 (USD; Tot_Drug_Cst)2018 Drug cost: $26,170 (USD; Tot_Drug_Cst)2019 Drug cost: $7,907 (USD; Tot_Drug_Cst)2020 Drug cost: $11,191 (USD; Tot_Drug_Cst)2021 Drug cost: $7,702 (USD; Tot_Drug_Cst)2022 Drug cost: $6,571 (USD; Tot_Drug_Cst)2023 Drug cost: $4,029 (USD; Tot_Drug_Cst)2024 Drug cost: $6,396 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201549102$12,766
201659121$14,611
201787176$20,674
201886191$26,170
20194473$7,907
202064107$11,191
202185131$7,702
2022116181$6,571
202393124$4,029
2024124205$6,396

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg1851,724$656
67028Injection of drug into eye2981,506$108
92014Established patient complete exam of visual system508753$100
99426Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month153830$53
92134Imaging of retina7252,190$32

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha1413,790$1,732

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.25$1,106Genentech, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Miriah Michael Teeter, M.D.?

Tedicare shows public-source Medicare data for Miriah Michael Teeter, M.D. (NPI 1316141872), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Miriah Michael Teeter, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Miriah Michael Teeter, M.D.?

Miriah Michael Teeter, M.D. is linked to COLORADO RETINA ASSOCIATES, PLLC (billing NPI 1790876159) in the available physician profile data.

Does Miriah Michael Teeter, M.D. have Open Payments data?

Miriah Michael Teeter, M.D. has 25 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.